ANTICOAGULATION THERAPY OR CATHETER DIRECTED THROMBOLYSIS Alice Marinho, Carlos Veterano, Maricruz Nunes, Patrícia Baptista, Pedro Aguiar, Pedro Campelo,

Slides:



Advertisements
Similar presentations
A Comparison of Early Versus Late Initiation of Renal Replacement Therapy in Critically III Patients with Acute Kidney Injury: A Systematic Review and.
Advertisements

Rocky Mountain ACP Internal Medicine Conference November 22, 2012 Brian Wirzba, MD, FRCPC, FACP.
Turma 6 Bárbara Vieira, Diana Pires, Iolanda Vieira, João Novo, José Machado, Lia Rodrigues, Maria Lume, Mário Sousa, Mónica Pereira, Patrícia Gouveia,
Stacey Graven, ACNP Vascular Surgery, Springfield Clinic Springfield, Illinois.
Suresh Vedantham, M.D. Interventional Radiologist Associate Professor of Radiology & Surgery Washington University School of Medicine Vice-Chair, Venous.
Aggressive Management of Chronic Deep Venous Thrombosis: Technical and Clinical Outcomes Mark J. Garcia M.D. FSIR C Grilli, M McGarry, M Ali, D Agriantonus,
Chapter Six Venous Disease Coalition Acute Management of VTE VTE Toolkit.
VTE in abdominal-pelvic surgery patients
+ Deep Vein Thrombosis Common, Preventable, and potentially Fatal.
Results: 1.Progression of thrombus length and volume (40% vs. 28%; P
Long-Term Outcome After Additional Catheter-Directed Thrombolysis versus Standard Treatment for Acute Iliofemoral Deep Vein Thrombosis (The CaVenT Study):
Antithrombotic Therapy for Venous Thromboembolic Diseases
Joint Hospital Surgical Grand Round
QUICK DESIGN GUIDE (--THIS SECTION DOES NOT PRINT--) This PowerPoint 2007 template produces a 36”x60” professional poster. It will save you valuable time.
In patients with Gastroesophageal Reflux Disease is Esomeprazole the most effective proton pump inhibitor to induce mucosal healing and/or to maintain.
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
DPT 732 SPRING 2009 S. SCHERER Deep Vein Thrombosis.
Deep vein thrombosis. Color duplex scan of DVT Venogram shows DVT.
LIFEBLOOD THE Thrombosis CHARITY Venous thromboembolism – Treatment and secondary prevention Ulcus cruris Chronic PE PE DVT Post-thrombotic syndrome Death.
Unprovoked DVT in a young patient
Chapter Nine Venous Disease Coalition New Therapies for VTE VTE Toolkit.
Isolated Thrombolysis for DVT DVT Treatment with the Trellis ® Peripheral Infusion System Manufacturer’s Registry Report Gerard J. O’Sullivan MD Mahmood.
Pulmonary Embolism Jeannette Corona. Title: Alteplase Treatment of Acute Pulmonary Embolism in the Intensive Care Unit Authors: Pamela L. Smithburger,
1. 2 Definition Definition Causes Causes Risk Factors Risk Factors Symptoms Symptoms Importance Importance Treatments Treatments Content Introduction.
Supervisor: Vs 余垣斌 Presenter: CR 周益聖. INTRODUCTION.
Aspirin Plus Coumarin Versus Aspirin Alone in the Prevention of Reocclusion After Fibrinolysis for Acute Myocardial Infarction Results of the Antithrombotics.
Renal vein thrombosis Nephrology discussion Dr. Coetser Prof. Van Rensburg and dr. Rossouw.
Oral Rivaroxaban for Symptomatic Venous Thrombroenbolism Group /06/11.
Evidence based stroke medicine. Evaluating treatments for acute ischaemic stroke -what works and what doesn’t? Professor Peter Sandercock.
Peripheral Vascular Disease Megan McClintock. Peripheral Artery Disease Definition Etiology/Pathophysiology Signs & symptoms Complications Diagnostic.
CARDIOVASCULAR MODULE: DEEP VENOUS THROMBOSIS THROMBOPHLEBITIS Adult Medical-Surgical Nursing.
Pulmonary Embolism Treatment in Cancer - Is It Different 34th Brazilian Thoracic Conference 6th ALAT Congress 5th Brazil-Portugal Congress Brazilia/DF.
H.R. Buller, G. Agnelli Presented at the XXIst Congress of International Society on Thrombosis and Haemostasis (ISTH) 2007 Meeting, July 6-12th in Geneva,
MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.
PHLEGMASIA Tracy Groller & Deb Halliday Journal Article Presentation MEDU 610 Professor: Camie Modjadidi April 7, 2011.
Evidence in the ED Byron Drumheller, MD Penn Emergency Medicine.
Acute venous or arterial thrombosis Acute venous or arterial thrombosis Is there clinical concern for an anatomic compressive syndrome or occlusive iliofemoral.
Amy Leung Intern, Mater Health Services
Evidence based stroke medicine. Evaluating treatments for acute ischaemic stroke -what works and what doesn’t? Professor Peter Sandercock.
Radial versus Femoral Approach for Percutaneous Coronary Procedures: A Meta-analysis of Randomized Trials 6th EUROPEAN WORKSHOP ON TRANSRADIAL APPROACH.
Intra - Arterial Thrombolysis for acute stroke
Presented by: Passant Mounir Nagy Under the supervision of: Prof. Dr/ Seham Hafez.
Deep vein thrombosis Pulmonary embolism Deep vein thrombosis Pulmonary embolism Venous Thromboembolism TreatmentTreatment …All the same?
IVC filters what you need to know Sam Chakraverty Consultant Radiologist Ninewells Hospital Dundee, Scotland.
Jomo Osborne Lung-2015 Baltimore, USA July , 2015.
Oral Rivaroxaban for Symptomatic Venous Thromboembolism.
Class 15, 1st year Introdução à Medicina II 28th May 2010
Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction The HORIZONS-SWITCH Analysis HORIZONS AMI Dangas G, et al.
Pulmonary Embolism Pulmonary embolism is blockage in one or more arteries in your lungs. Maggie Trainor.
A Randomized Trial of Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism Schulman S et al. Proc ASH 2011;Abstract 205.
DVT & PE: How early can I mobilize a patient ??
Acute Venous Pulmonary Embolism Restore cardiopulmonary hemodynamics Avoid recurrence Avoid chronic thromboembolic pulmonary hypertension Restore cardiopulmonary.
Duration of Anticoagulation 5 Patients Categories 3. First Episode: 4. First Episode: 5.Recurrent DVT 2. First Episode: 1. First Episode: Transient risk.
 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.
Ambulatory Venous Hypertension Components Obstruction Valve incompetence Obstruction Valve incompetence Obstruction and valve incompetence …Highest venous.
Agents Affecting Blood Clotting
Thrombolysis for acute ischaemic stroke Clinical
Oral Rivaroxaban Compared with Subcutaneous Enoxaparin for Extended Thromboprophylaxis After Total Hip Arthroplasty: The RECORD1 Trial Eriksson BI, Borris.
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism ‘ The PADIS-PE Trial’ Nate Peyton.
Treatment of deep venous thrombosis and pulmonary embolism Anders Waage.
Current Standards for Treatment of DVT
By: Dr. Nalaka Gunawansa
The efficacy and safety of oral Rivaroxaban in patients with permanent inferior vena cava filter: a pilot case-control study Lobastov K., Barinov V.,
Recanilization of Central Venous Total Occlusions
Clinical Presentations of VTEa,b NOACs VTE Acute Treatment Trials.
Comparison of vein valve function following pharmacomechanical thrombolysis versus simple catheter-directed thrombolysis for iliofemoral deep vein thrombosis 
Paclitaxel-coated balloon reduces target lesion revascularization compared with standard balloon angioplasty  Nicholas Candy, MBBS, Eugene Ng, MBBS, Ramesh.
A meta-analysis of anticoagulation for calf deep venous thrombosis
Post-thrombotic Syndrome.
pulmonary embolism protocol -- EMB review
Presentation transcript:

ANTICOAGULATION THERAPY OR CATHETER DIRECTED THROMBOLYSIS Alice Marinho, Carlos Veterano, Maricruz Nunes, Patrícia Baptista, Pedro Aguiar, Pedro Campelo, Rosana Dias, Sandra Santos, Sara Peixoto Class 20 Introdução à Medicina II May 2011 ILIO-FEMORAL THROMBOSIS Mestrado Integrado em Medicina

1. Background Introdução à Medicina II March 2011

1. Background Image 1 Deep Venous Thrombosis (DVTs) Ilio-femoral Vein Deep Venous Thrombosis (DVTs) Ilio-femoral Vein “Deep venous thrombosis (DVTs) are a significant cause of morbidity and mortality in the general population” [1] Introdução à Medicina II March 2011 [1] Gogalniceanu P, Johnston CJ, Khalid U, Holt PJ, Hincliffe R, Loftus IM, Thompson MM; Indications for thrombolysis in deep venous thrombosis, 2009

1. Background Introdução à Medicina II March 2011 Anticoagulation therapy Catheter directed thrombolysis

1. Background: Anticoagulation Therapy Introdução à Medicina II March 2011 Low-molecular- weight Heparin (Enexoparin) Unfractionated heparin ANTICOAGULATION THERAPY Raham Ali et Al.; A comparison of different treatment managements in patients with acute deep vein thrombosis by the effects on enhancing venous ontflow in the lower limb, 2009 Image 2 Vitamin K Antagonists

1. Background: Catether directed-thrombolysis Introdução à Medicina II March 2011  Thrombolytic agent: urokinase or streptokinase or rtPA  Venous approach to ilio-femoral vein: popliteal common femoral  Cava filters, venous stents and angioplastic balloon  Thrombolytic agent: urokinase or streptokinase or rtPA  Venous approach to ilio-femoral vein: popliteal common femoral  Cava filters, venous stents and angioplastic balloon Image 4Image 3 T. Wicky Stephan; Acute Deep Vein Thrombosis and Thrombolysis; 2009 Image 5

2. Research question Introdução à Medicina II March 2011

Measure: Lysis Patency Complications Recurrency Recovery of limb function Image 6 – Clot formation 3. Aims Introdução à Medicina II March 2011

4. Methodology: Query (venous thrombosis OR thrombus OR clot OR venous blockage) AND (femoral vein OR ilio-femoral vein) AND (heparin OR catheter directed thrombolysis OR anticoagulation therapy OR thrombolytic therapy) Introdução à Medicina II March 2011 Image 9 Image 7 Image 8 Data bases: Pubmed, Scopus, Cochrane

4. Methodology: Selection Criteria Inclusion criteria Condition under study: deep- venous thrombosis Affected vein: iliofemoral vein Treatment used: anticoagulation therapy or CDT Variables measured: mortality, efficency, life quality after treatment, recurrency, patency, venous obstruction, etc. Exclusion criteria Idiom: other than Portuguese, English or Spanish Population: other that adult humans with no other significant health problems. Introdução à Medicina II March 2011 Image 10

4. Methodology: Articles’ Selection 215 articles 33 articles 23 articles included Read title Read Abstract Read full text Introdução à Medicina II March 2011 Pubmed, Scopus, Cochrane 4 clinical trials that compare both treatments 15 systematic reviews 8 clinical trials

Introdução à Medicina II March 2011 a) Was the study described as randomized? b) Was the study described as double-blind? c) Was there a description of withdrawals and drop-outs? YES = 1NO = 0 Add 1 point if Randomization and double- blinding are appropriate Deduct 1 point if  Randomization and double- blinding are not appropriate

Introdução à Medicina II March clinical trials 2 with 3 points 2 with 5 points Numeric scale 0-5

Introdução à Medicina II March 2011 SPSS – calculating Odds Ratio GraphPad Prism – building Forest Plots Image 11 – GraphPad’s window

Introdução à Medicina II March 2011 Treatment CDTAT Lysis II III ab Icd OR = (a/c)/(b/d) Greater with AT Greater with CDT Grade of DVT lysis Grade I < 50% lysis Grade II 50 – 99% lysis Grade III complete lysis SATISFACTORY RESULTS 5. Results: Lysis

Introdução à Medicina II March 2011 Treatment CDTAT Venous Obstruction +ab -cd OR = (a/c)/(b/d) Greater with AT Greater with CDT 5. Results: Venous Obstruction

Introdução à Medicina II March 2011 In short-term follow-up, patients treated with CDT obtain better patency than those treated with standard anticoagulation therapy. [1,2,3] [ 1] M. Elshrawy et al. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomized clinical trial. 2002, Eur J Vasc endovasc Surg [2] Ali F. AbuRahma, MD et al. Ilio femoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. 2001, annals of surgery. [3] T. Enden et al. Catheter-directed thrombolysis vs anticoagulation therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. 2009, Journal of Thrombosis and Haemostasis. 5. Results: Patency

5_Results: Recurrency Introdução à Medicina II March 2011 [4] Y. J. Park et al. Restoration of patency in iliofemoral deep vein thrombosis with catheter-diected thrombolysis does not always prevent post-thrombotic damage [5] Ali F. AbuRahma, MD et al. Ilio femoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. 2001, annals of surgery. [6] N.Baekgaard et al. Long-term results using catheter directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. 2010, Eur J Vasc Endovasc Surg. CDT followed by anticoagulation therapy leads to much lower recurrency rate than anticoagulation alone. [4,5,6] Image 13 – Thrombus formation

Introdução à Medicina II March 2011 THROMBOCYTOPENIA 5. Results: Anticoagulation Therapy Complications

Introdução à Medicina II March 2011 Occurence of bleeding in 5 – 11%b of the patients Pulmonary embolism: 4,5% Death: 0% – 0,4% Pain: caused by the application of a stent puncture site bleeding [1] Bad measure of efficacy intracranial haemorrhage (uncommon) [2] [1] [1] Gogalniceanu P., Indications for thrombolysis in Deep Venous Thrombosis [2] Bækgaard N., Long-Term Results using Catheter- directed Thrombolysis in 103 Lower Limbs with Acute Iliofemoral Venous Thrombosis Lung The thrombus goes to the lungs trough the vena cava. Image Results: CDT Complications

Introdução à Medicina II March Discussion Catheter Directed Thrombolysis Anticoagulation Therapy Effective lysis Greater patency Less venous obstruction Recurrent DVT Pulmonary Embolism Salvage of venous valves Reduced PTS allowsprevents

Introdução à Medicina II March 2011 Anticoagulation Therapy Catheter Directed Thrombolysis VS 7. Conclusion

Introdução à Medicina II March Website